You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: P24 IMPROVEMENT OF CHROMOGENIC ANTI-XA ASSAY TO MEASURE BETRIXABAN CONCENTRATION IN PLASMA

€3.03

SKU: product-article-23808 Category: General

Description
Reviews (0)

Description

P24 IMPROVEMENT OF CHROMOGENIC ANTI-XA ASSAY TO MEASURE BETRIXABAN CONCENTRATION IN PLASMA

Reviews

There are no reviews yet.

Be the first to review “Article: P24 IMPROVEMENT OF CHROMOGENIC ANTI-XA ASSAY TO MEASURE BETRIXABAN CONCENTRATION IN PLASMA”

You must be logged in to post a review.

Top

Article: P24 IMPROVEMENT OF CHROMOGENIC ANTI-XA ASSAY TO MEASURE BETRIXABAN CONCENTRATION IN PLASMA

Description

Reviews

Related products

Article: Highlights in gynaecological cancers

Article: Highlights in urologic cancer

Article: Highlights in melanoma

Article: INTRODUCTION